SEC Form 4 · accession 0001209191-15-072343
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Benedict
Officer — Sr. VP Finance
Period of report
Sep 24, 2015
Accepted (ET)
Sep 28, 2015 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 24, 2015 | M | 5,454 | $0.99 | A | 6,720 | D | |
| Common Stock | Sep 24, 2015 | M | 9,090 | $4.455 | A | 15,810 | D | |
| Common Stock | Sep 24, 2015 | M | 10,437 | $3.465 | A | 26,247 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.99 | Sep 24, 2015 | M | 5,454 | D | — | Apr 20, 2019 | Common Stock | 5,454 | 0 | D |
| Stock Option (Right to Buy)F1 | $4.455 | Sep 24, 2015 | M | 9,090 | D | — | Feb 25, 2020 | Common Stock | 9,090 | 0 | D |
| Stock Option (Right to Buy)F2 | $3.465 | Sep 24, 2015 | M | 10,437 | D | — | Jun 12, 2022 | Common Stock | 10,437 | 7,744 | D |
Explanation of responses
- F1The option is fully vested.
- F2The shares subject to this option vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of the vesting commencement date and 1/48th of the total number of shares each monthly anniversary of the vesting commencement date thereafter, for so long as the recipient of the option provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.